FDANews
www.fdanews.com/articles/87502-news-from-medivir-s-ongoing-r-d-day

NEWS FROM MEDIVIR'S ONGOING R&D DAY

June 12, 2006

Medivir is presenting an R&D update this afternoon on oral herpes project Lipsovir (ME 609) and the company's protease-based projects on Hepatitis C, osteoporosis and COPD (Chronic Obstructive Pulmonary Disease). A short summary will also be given on the status of the spin out process for the company's HIV projects, Medivir HIV Franchise AB.
Genetic Engineering News